The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

The concept of chronic kidney disease–mineral bone disorder (CKD-MBD) does not appear
to fulfil the requirements for a syndrome at first glance, but its definition has brought some …

In CKD, phosphate retention arising from diminished GFR is a key early step in a pathologic
cascade leading to hyperthyroidism, metabolic bone disease, vascular calcification, and …

Secondary hyperparathyroidism (SHPT), a very frequent, severe, and worsening
complication of chronic kidney disease, is characterized by high serum parathyroid hormone …

Elevated serum phosphorus levels are common in patients with chronic kidney disease and
are associated with heart and vascular disease, conditions that in turn are associated with …

In chronic kidney disease (CKD), the first cause of mortality is cardiovascular disease
induced mainly by vascular calcification (VC). Recently, iron-based phosphate binders have …

Background. Ascorbic acid (AA) supplementation has been suggested to afford
erythropoietin hyporesponsiveness and high levels of ferritin in haemodialysis (HD) patients …

Secondary hyperparathyroidism (SHPT) is a major complication of chronic kidney disease
(CKD), responsible for skeletal and vascular damage with increased risk of bone fractures …

Dietary management of chronic kidney disease (CKD) focusses on limiting the intake of
substances that might accumulate to toxic levels (such as potassium, phosphorus or salt) …

Introduction: Secondary hyperparathyroidism (SHPT), a common, serious, and progressive
complication of chronic kidney disease (CKD), is characterized by elevated serum …